White Paper: Improving next-generation sequencing workflows with droplet digital PCR

The ability of next-generation sequencing (NGS) technologies to interrogate a broad range of genetic mutations simultaneously has made it a central technique in Cancer research, supporting tumor profiling, biomarker discovery and resistance mechanism identification. However, progress in the achievement of read-depth consistency and uniform coverage, particularly in low-input heterogeneous samples like FFPE tissue and liquid biopsies, has lagged behind advances in accessibility and throughput.

This White Paper explores how ddPCR can help support NGS workflows, relieving bottlenecks in the process, before examining key use cases of ddPCR in tandem with NGS.

Complete the form below to download the White Paper.

Can’t see the form below? Download the content here.

In association with: